semaglutide compounding fda enforcement today free to pursue compounders after latest court ruling Semaglutide for weight loss |

Total content

Global Perspective: BPC-157's use in other countries with reported success raises questions about the FDA's stricter stance compared to other regions

IGF-1 LR3's structural modifications allow it to remain unbound and biologically active for 2030 hours post-injection, delivering sustained systemic exposure to IGF-1 receptor signaling

Milk Protein & Shea Butter Helps soften, smooth, and condition dry skin

This is a bit nerdy but stick with me - Eli Lilly announced that theyll be filing for approval with the FDA in Q1 of 2027, but theyre preparing a Biologics License Application (BLA), not a New Drug Application (NDA)